Bruce L. Miller, MD, Chief Medical Officer of The John Douglas French Alzheimer's Foundation, has been elected to the National Academy of Medicine.
Election to the National Academy of Medicine is one of the highest honors in the fields of health and medicine, recognizing individuals who have demonstrated outstanding professional achievements and commitment to service in the medical sciences, health care and public health — in Dr. Miller’s case, as a contrarian who believed the type of disease causing dementia symptoms in a patient could be determined while the patient was still alive.
Dr. Miller, who is the A. W. and Mary Margaret Clausen Distinguished Professor in Neurology and Director of the UCSF Memory and Aging Center, is principal investigator of the NIH-sponsored Alzheimer’s Disease Research Center, co-director of the Global Brain Health Institute, and leader of two philanthropy-funded research consortia, the Tau Consortium and the Consortium for Frontotemporal Research.
He has received numerous awards including the Potamkin Award from the American Academy of Neurology, the Raymond Adams Award from the American Neurological Association and the Wallace Wilson Distinguished Alumni Award from the University of British Columbia.
We are proud to note that Dr. Miller has served as the Chief Medical Officer of The John Douglas French Alzheimer's Foundation since it was founded in 1983. In that time, Dr. Miller has overseen several hundred research projects funded by the Foundation. We congratulate Dr. Miller on this recognition of his enormous talent, deep dedication, and true compassion.